The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Bespoke circulating tumor DNA (ctDNA) analysis as a predictive biomarker in solid tumor patients (pts) treated with single-agent pembrolizumab (P).
 
Marco Adelmo James Iafolla
No Relationships to Disclose
 
Cindy Yang
No Relationships to Disclose
 
Scott Dashner
Employment - Natera
Research Funding - Natera (Inst)
Travel, Accommodations, Expenses - Natera
 
Wei Xu
No Relationships to Disclose
 
Aaron Richard Hansen
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline/Novartis; Merck; Pfizer
Consulting or Advisory Role - Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Merck; Novartis
Research Funding - Boehringer Ingelheim; Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Novartis (Inst)
 
Philippe L. Bedard
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Lilly (Inst); Merck (Inst); Mersana (Inst); Nektar (Inst); Novartis (Inst); PTC Therapeutics (Inst); Sanofi (Inst); Seagen (Inst); SERVIER (Inst); SignalChem (Inst)
 
Stephanie Lheureux
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca
Research Funding - AstraZeneca (Inst); Regeneron (Inst); Roche/Genentech (Inst); Tesaro (Inst)
 
Anna Spreafico
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis; Oncorus
Research Funding - AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Janssen Oncology; Merck; Northern Biologics; Novartis; Surface Oncology; Surface Oncology; Symphogen
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Idera; Merck
 
Albiruni Ryan Abdul Razak
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; Merck
Research Funding - Abbvie; Adaptimmune; Amgen; Blueprint Medicines; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; CASI Pharmaceuticals; Deciphera; GlaxoSmithKline; Karyopharm Therapeutics; Lilly; MedImmune; Merck; Novartis; Pfizer; Roche/Genentech
 
Hsin-Ta Wu
Employment - Natera
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
Svetlana Shchegrova
Employment - Natera
Stock and Other Ownership Interests - Natera
 
Zhihui (Amy) Liu
No Relationships to Disclose
 
Pamela S Ohashi
Consulting or Advisory Role - Providence Therapeutics; Symphogen
 
Dax Torti
No Relationships to Disclose
 
Maggie C Louie
Employment - Natera
Stock and Other Ownership Interests - Natera
Consulting or Advisory Role - Clear Gene
 
Himanshu Sethi
Employment - Natera
Stock and Other Ownership Interests - Natera
Research Funding - Natera (Inst)
Patents, Royalties, Other Intellectual Property - Various Patents
Travel, Accommodations, Expenses - Natera
 
Alexey Aleshin
Employment - Natera; Natera
Stock and Other Ownership Interests - Natera
 
Lillian L. Siu
Leadership - Agios (I)
Stock and Other Ownership Interests - Agios (I)
Consulting or Advisory Role - AstraZeneca/MedImmune; Loxo; Merck; MorphoSys; Roche; Symphony Evolution
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Symphony Evolution (Inst)
 
Scott Victor Bratman
Patents, Royalties, Other Intellectual Property - Co-inventor and holder of a patent related to circulating tumor DNA detection technology.
 
Trevor John Pugh
Honoraria - Chrysalis Biomedical Advisors; Merck; Prosigna
Consulting or Advisory Role - DynaCare
Research Funding - Boehringer Ingelheim (Inst)
Patents, Royalties, Other Intellectual Property - Combined hybrid-capture DNA sequencing for disease detection; Hybrid-capture sequencing for dete rmining immune cell clonality